|
PRESCRIPTION REQUIRED: Click Here for more information.
Various sizes - View product for choices
Description
Beige brown spotted round
tablets.
Marbocyl P 20 mg containing 20 mg marbofloxacin. For use in dogs and
cats.
Uses
In Dogs
Marbocyl is indicated for the
treatment of skin and soft tissue infections (skin fold pyoderma, impetigo,
folliculitis, furunculosis, cellulitis), for the treatment of urinary tract
infections associated or not with prostatitis and respiratory tract infections,
caused by susceptible strains of organisms.
In Cats (Marbocyl P 5mg Tablet
only)
Marbocyl is indicated for the treatment of skin and soft tissue
infections (wounds, abscesses, phlegmons) and upper respiratory tract infections
caused by susceptible strains of organisms.
Dosage
The
recommended dose rate is 2 mg/kg per day in a single daily administration.
In
dogs for the treatment of skin and soft tissue infections, treatment duration is
at least five days. Depending on the course of the disease it may be extended up
to 40 days. In urinary tract infections, treatment duration is at least 10 days.
Depending on the course of the disease it may be extended up to 28 days. In
respiratory infections, treatment duration is at least 7 days and, depending on
the course of the disease, may be extended up to 21 days.
In cats for the
treatment of skin and soft tissue infections, treatment duration is 3–5 days.
For upper respiratory infections, treatment duration is 5
days.
Contra-indications,
warnings, etc
Marbofloxacin should not be used in dogs aged less
than 12 months or less than 18 months for exceptionally large breeds of dogs,
such as Great Danes, Briard, Bernese, Bouvier and Mastiffs with a longer growth
period. Not recommended for use in cats aged less than 16 weeks.
Not suitable
for infections resulting from strict anaerobes, yeast or fungi.
The
fluoroquinolones have been shown to induce erosion of articular cartilage in
juvenile dogs and care should be taken to dose accurately, especially in young
animals.
The fluoroquinolones are known for their potential neurological side
effects; cautious use is recommended in dogs and cats diagnosed as suffering
from epilepsy.
A low urinary pH could have an inhibitory effect on the
activity of Marbofloxacin.
Mild side effects such as vomiting, softening of
faeces, modification of thirst or transient increase in activity may
occasionally occur. These signs cease spontaneously after treatment and do not
necessitate cessation of the treatment.
At the therapeutic recommended dosage
no severe side effects are to be expected. In particular no lesions of the
articular joints were encountered in clinical studies at the recommended dose
rate.
Studies in pregnant rats and rabbits showed no side effects on
pregnancy. However, no specific studies have been carried out in pregnant cats
and dogs.
Fluoroquinolones are known to interact with orally administered
cations (Aluminium, Calcium, Magnesium, Iron.) In such cases, the
bioavailability may be reduced.
Overdosage may cause acute signs in the form
of neurological disorders which should be treated symptomatically.
Do not use
Marbocyl P 20mg or Marbocyl P 80mg tablets in cats. For the treatment of this
species the Marbocyl P 5mg tablet is available.
Withdrawal
periods
Not applicable
Operator
warning
People with known hypersensitivity to fluoroquinolones
should avoid using this product. In case of accidental ingestion seek medical
attention and show product label and/or package leaflet to the doctor. Wear
gloves when handling or dividing tablets. Wash hands after
use.
This item can be dispensed in any quantity. Enter
the number your prescription permits in to the Quantity
box
 |
